India’s Supreme Court recently rejected a request from Novartis for a second patent for its cancer drug Gleevec. Forty other count...

*Please Login to read the the full content... *

Publication Date: Wednesday, May 01, 2013

Login Required

If you are an existing member, please log in below. Username and password are required.



Forgot User Name?
Forgot Password?